Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Radionuclide Therapy With 177Lu-PSMA in a Case of Metastatic Adenoid Cystic Carcinoma of the Parotid

Has Simsek, Duygu MD*; Kuyumcu, Serkan MD*; Agaoglu, Fulya Yaman MD; Unal, Seher Nilgun MD*

doi: 10.1097/RLU.0000000000002645
Interesting Images
Buy

In vivo prostate-specific membrane antigen (PSMA) overexpression creates an opportunity for PSMA-directed theranostic approach in adenoid cystic carcinoma of the parotid. Herein, we illustrate a patient with metastatic PSMA-directed theranostic approach in adenoid cystic carcinoma of the parotid who had intense PSMA uptake on metastatic lesions, followed by radionuclide therapy with 177Lu-PSMA.

From the *Department of Nuclear Medicine, Istanbul Faculty of Medicine, Istanbul University

Department of Radiation Oncology, Faculty of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.

Received for publication March 14, 2019; revision accepted April 20, 2019.

Conflicts of interest and sources of funding: none declared.

Correspondence to: Duygu Has Simsek, MD, Department of Nuclear Medicine, Istanbul Faculty of Medicine, Istanbul University, 34093 Fatih/İstanbul, Turkey. E-mail: dr.duyguhas@hotmail.com.

Online date: June 3, 2019

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.